News

A change of course is needed if we are to keep healthcare in the Netherlands accessible. The South Limburg Regional Plan, presented in late 2023, focuses on cooperation between dozens of parties and organisations. Researchers Daan Westra and Svenja Cremer explain the contribution that Maastricht University is making through its Academic Collaborative Centres.

Imagine university graduates entering the workforce with not just diplomas, but also the professional skills to collaborate, communicate, and lead. This vision drives Daniëlle Zijlstra's research fellowship project at EDLAB. 

Faculty of Law and AMBER Alert Europe join forces to protect missing children.

The Executive Board has appointed Sarah as Professor with effect from 1-1-2025.

The Executive Board has appointed Sjoerd as Professor with effect from 1-1-2025.

Vascular surgeon Barend Mees (CARIM) delivered his inaugural lecture about vascular regenerative medicine, building bridges and big dreams.

On 17 January, Dutch snowboarder Thom Vogel, student at the School of Business and Economics (SBE) at Maastricht University, won a silver medal in slopestyle during the FISU World University Games Winter 2025.

Studio Europa Maastricht sat down with Dr. Sally Wyatt, Professor of Digital Cultures at Maastricht University, to discuss the potential impact of Meta’s recent decisions on democratic processes in the U.S. and Europe, how regulatory differences—such as the absence of the DSA in the U.S.—will shape online spaces on both sides of the Atlantic, and whether the DSA can effectively challenge American big tech companies.

It probably hasn't escaped your attention that we are dealing with a disruption in our network. At the moment, the network varies from working just fine to being really slow or going down completely. The disruption has an external cause and is targeting the shared SURF servers of educational institutions. UM is therefore not the only institution experiencing problems. 

Obesity is one of the great public health problems we face. New drugs such as Ozempic offer possibilities but also raise moral, economic and health questions. Why is ‘just lose some weight’ naïve and unempirical? Why might covering Ozempic be cheaper for health insurers? We brought together experts Anne Roefs, Gijs Goossens and Mickaël Hiligsmann to talk about obesity and its new miracle cure.